Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
JAMA Oncology Author Interviews
00:00
Is There a Risk of Missing Something?
We cannot conclude exact why it is that we're seeing this effect. But of course, longer follow up time would be beneficial. There were differences in the patients who were on five alpharoductes inhibitors having higher rates of p s a check per year and biopses per year. And you can't tell from the data we have available which of these or both might be contribute.
Play episode from 08:09
Transcript


